Zacytuj

Fig. 1.

Visual description of the study (N – number of patients; SOFA - Sequential Organ Failure Assessment; APACHE II - Acute Physiology and Chronic Health Evaluation II; SAPS II - Simplified Acute Physiology Score II)
Visual description of the study (N – number of patients; SOFA - Sequential Organ Failure Assessment; APACHE II - Acute Physiology and Chronic Health Evaluation II; SAPS II - Simplified Acute Physiology Score II)

Figure 2.

Distribution by age
Distribution by age

Figure 3.

Distribution by mortality
Distribution by mortality

Fig. 4.

Positive correlation between SOFA vs. APACHE II and SOFA vs. SAPS II. No correlation between SOFA vs. NLR and SOFA vs. COHb levels on D1 (SOFA – Sequential Organ Failure Assessment; APACHE II – Acute Physiology and Chronic Health Evaluation II; SAPS II – Simplified Acute Physiology Score II; NLR – Neutrophil-Lymphocytes Ratio; COHb – Carboxyhaemoglobin; D1 – day 1)
Positive correlation between SOFA vs. APACHE II and SOFA vs. SAPS II. No correlation between SOFA vs. NLR and SOFA vs. COHb levels on D1 (SOFA – Sequential Organ Failure Assessment; APACHE II – Acute Physiology and Chronic Health Evaluation II; SAPS II – Simplified Acute Physiology Score II; NLR – Neutrophil-Lymphocytes Ratio; COHb – Carboxyhaemoglobin; D1 – day 1)

Fig. 5.

Positive correlation between APACHE II vs. SAPS II. No correlation between APACHE II vs. NLR, APACHE II vs. COHb levels on D1 (APACHE II – Acute Physiology and Chronic Health Evaluation II; SAPS II – Simplified Acute Physiology Score II; NLR – Neutrophil-Lymphocytes Ratio; COHb – Carboxyhaemoglobin; D1 – day 1)
Positive correlation between APACHE II vs. SAPS II. No correlation between APACHE II vs. NLR, APACHE II vs. COHb levels on D1 (APACHE II – Acute Physiology and Chronic Health Evaluation II; SAPS II – Simplified Acute Physiology Score II; NLR – Neutrophil-Lymphocytes Ratio; COHb – Carboxyhaemoglobin; D1 – day 1)

Fig. 6.

No correlation between SAPS II vs. NLR, SAPS II vs. COHb levels on D1 (SAPS II – Simplified Acute Physiology Score II; NLR – Neutrophil-Lymphocytes Ratio; COHb – Carboxyhaemoglobin; D1 – day 1)
No correlation between SAPS II vs. NLR, SAPS II vs. COHb levels on D1 (SAPS II – Simplified Acute Physiology Score II; NLR – Neutrophil-Lymphocytes Ratio; COHb – Carboxyhaemoglobin; D1 – day 1)

Fig. 7.

Negative correlation between NLR vs. COHb on D1 (NLR – Neutrophil-Lymphocytes Ratio; COHb – Carboxyhaemoglobin; D1 – day 1)
Negative correlation between NLR vs. COHb on D1 (NLR – Neutrophil-Lymphocytes Ratio; COHb – Carboxyhaemoglobin; D1 – day 1)

Fig. 8.

Positive correlation between SOFA vs. APACHE II, SOFA vs. SAPS II. No correlation between SOFA vs. NLR and SOFA vs. COHb levels on D5 (SOFA – Sequential Organ Failure Assessment; APACHE II – Acute Physiology and Chronic Health Evaluation II; SAPS II – Simplified Acute Physiology Score II; NLR – Neutrophil-Lymphocytes Ratio; COHb – Carboxyhaemoglobin; D5 – day 5)
Positive correlation between SOFA vs. APACHE II, SOFA vs. SAPS II. No correlation between SOFA vs. NLR and SOFA vs. COHb levels on D5 (SOFA – Sequential Organ Failure Assessment; APACHE II – Acute Physiology and Chronic Health Evaluation II; SAPS II – Simplified Acute Physiology Score II; NLR – Neutrophil-Lymphocytes Ratio; COHb – Carboxyhaemoglobin; D5 – day 5)

Fig. 9.

Positive correlation between APACHE II vs. SAPS II. No correlation between APACHE II vs. NLR, APACHE II vs. COHb levels on D5 (APACHE II – Acute Physiology and Chronic Health Evaluation II; SAPS II – Simplified Acute Physiology Score II; NLR – Neutrophil-Lymphocytes Ratio; COHb – Carboxyhaemoglobin; D5 – day 5)
Positive correlation between APACHE II vs. SAPS II. No correlation between APACHE II vs. NLR, APACHE II vs. COHb levels on D5 (APACHE II – Acute Physiology and Chronic Health Evaluation II; SAPS II – Simplified Acute Physiology Score II; NLR – Neutrophil-Lymphocytes Ratio; COHb – Carboxyhaemoglobin; D5 – day 5)

Fig. 10.

No correlation between SAPS II vs. NLR, SAPS II vs. COHb levels on D5 (SAPS II – Simplified Acute Physiology Score II; NLR – Neutrophil-Lymphocytes Ratio; COHb – Carboxyhaemoglobin; D5 – day 5)
No correlation between SAPS II vs. NLR, SAPS II vs. COHb levels on D5 (SAPS II – Simplified Acute Physiology Score II; NLR – Neutrophil-Lymphocytes Ratio; COHb – Carboxyhaemoglobin; D5 – day 5)

Fig. 11.

No correlation between NLR vs. COHb on D5 (NLR – Neutrophil-Lymphocytes Ratio; COHb – Carboxyhaemoglobin; D5 – day 5)
No correlation between NLR vs. COHb on D5 (NLR – Neutrophil-Lymphocytes Ratio; COHb – Carboxyhaemoglobin; D5 – day 5)

Fig. 12.

Evolution of NLR on D1 and D5 in sepsis survivors and non-survivors (NLR – Neutrophil-Lymphocytes Ratio; D1 – day 1; D5 – day 5)
Evolution of NLR on D1 and D5 in sepsis survivors and non-survivors (NLR – Neutrophil-Lymphocytes Ratio; D1 – day 1; D5 – day 5)

Fig. 13.

Evolution of NLR on D1 and D5 in septic shock survivors and non-survivors (NLR – Neutrophil-Lymphocytes Ratio; SS – septic shock; D1 – day 1; D5 – day 5)
Evolution of NLR on D1 and D5 in septic shock survivors and non-survivors (NLR – Neutrophil-Lymphocytes Ratio; SS – septic shock; D1 – day 1; D5 – day 5)

Fig. 14.

Evolution of COHb (%) on D1 and D5 in sepsis survivors and non-survivors (COHb – Carboxyhaemoglobin; D1 – day 1; D5 – day 5)
Evolution of COHb (%) on D1 and D5 in sepsis survivors and non-survivors (COHb – Carboxyhaemoglobin; D1 – day 1; D5 – day 5)

Fig. 15.

Evolution of COHb (%) on D1 and D5 in septic shock survivors and non-survivors (COHb – Carboxyhaemoglobin; SS – septic shock; D1 – day 1; D5 – day 5)
Evolution of COHb (%) on D1 and D5 in septic shock survivors and non-survivors (COHb – Carboxyhaemoglobin; SS – septic shock; D1 – day 1; D5 – day 5)

Descriptive statistics on D1

SOFA APACHE II (points) SAPS II (points) NLR COHb
Minimum 1.000 7.000 17.00 0.7420 0.000
25% Percentile 6.000 14.00 34.50 8.236 0.4250
Median 9.000 22.00 56.00 14.14 1.100
75% Percentile 13.00 30.00 72.00 25.01 1.500
Maximum 19.00 44.00 118.0 59.67 2.500
Range 18.00 37.00 101.0 58.93 2.500
Mean 9.459 22.30 54.61 17.06 1.080
Std.Deviation 4.700 9.426 21.84 11.76 0.6356
Std. Error of Mean 0.6017 1.207 2.796 1.505 0.08206

Site of infection and aetiology of infection of patients included in the study.

Site of infection Number of patients Aetiology Number of patients
Pulmonary 36 Pneumonia / Bronchopneumonia 33
Abdominal 27 Peritonitis 12
Cutaneous 5 Intestinal obstruction 5
Urinary tract 4 Enterocolitis 2
Bloodstream 3 Sepsis / septic shock of unknown origin 2
Soft tissue 3 Pancreatitis 3
Biliary tract 1 Urinary tract infection 2
Unspecified 1 Cutaneous abscess 5
Prosthetic joint infection 1

Descriptive statistics on D5

SOFA APACHE II (points) SAPS II (points) NLR COHb
Minimum 0.000 5.000 15.00 0.7860 0.000
25% Percentile 2.000 11.00 29.00 5.422 0.600
Median 7.000 18.00 46.00 9.005 1.000
75% Percentile 12.00 27.00 61.00 17.87 1.500
Maximum 19.00 34.00 85.00 46.75 17.00
Range 19.00 29.00 70.00 45.96 17.00
Mean 7.359 18.74 45.36 13.03 1.471
Std. Deviation 5.334 9.318 20.40 10.84 2.550
Std. Error of Mean 0.8541 1.492 3.267 1.714 0.3982

Pathogens associated with infection of patients involved in the study.

Pathogens Number of patients
Pseudomonas aeruginosa 9

Klebsiella pneumoniae CPE 8
BLSE 2
unspecified 2

Acinetobacter baumanii 13

Proteus vulgaris 2

Enterococcus faecalis 5

Escherichia coli BLSE 4
unspecified 3

Staphylococcus arureus MRSA 1
MSSA 2

Streptococcus pneumoniae 1

Candida spp. 8

Clostridiumdifficile 3

Other 16

MDR Yes 13
No 48

Predictability of mortality by NLR and COHb variation from D1 to D5 of survivors and non-survivors

Survivors (n = 15) Non-survivors (n = 46)
NLRD1 ↓ D5 and COHb D1 ↓ D5 11 9
NLRD1 ↓ D5 and COHb D1 ↑ D5 1 14
NLRD1 ↑ D5 and COHb D1 ↑ D5 2 3
NLRD1 ↑ D5 and COHb D1 ↓ D5 0 4
NLR only on D1 and COHb only on D1 1 16
eISSN:
2393-1817
Język:
Angielski
Częstotliwość wydawania:
4 razy w roku
Dziedziny czasopisma:
Medicine, Clinical Medicine, Internal Medicine, other, Surgery, Anaesthesiology, Emergency Medicine and Intensive-Care Medicine